Cargando…
Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation
The primary end point for sepsis trial is 28-day mortality. However, additional methods for determining the efficacy may have benefits. The purpose of this study was to search a useful indicator of anticoagulant therapy in patients with sepsis with disseminated intravascular coagulation (DIC). Data...
Autores principales: | Iba, Toshiaki, Arakawa, Makoto, Mochizuki, Katsunori, Nishida, Osamu, Wada, Hideo, Levy, Jerrold H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714949/ https://www.ncbi.nlm.nih.gov/pubmed/30808223 http://dx.doi.org/10.1177/1076029618824044 |
Ejemplares similares
-
The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023) -
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019) -
The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023) -
Sepsis-associated disseminated intravascular coagulation and its differential diagnoses
por: Iba, Toshiaki, et al.
Publicado: (2019) -
Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2019)